MoneyWorks4Me

Vasundhara Rasayans informs about statement of investor complaints

10 Jan 2018 Evaluate

Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vasundhara Rasayans has informed about the Statement of Investor Complaints for the quarter ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..